Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse (NS)
Glomerular Disease
About this trial
This is an interventional treatment trial for Glomerular Disease focused on measuring Idiopathic Nephrotic syndrome relapse
Eligibility Criteria
Inclusion Criteria:
- Patients with Idiopathic nephrotic syndrome with a flair that needs steroids treatment.
Exclusion Criteria:
- Steroid resistance or treatment with Cyclosporin or Cellcept
Sites / Locations
- Shneider children Hospital Nephrology Institute
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
prednisone 60 mg/meter square Body Surface Aera
prednisone 45 mg/meter square BSA
prednisone 30 mg/meter squer BSA
A - 60 mg Prednisone/meter square Boby Surface Area( 30 twice)/day until there are 3 days of undetected protein in urine and tapering down to 40 mg ,30 mg, 20 mg ,10 mg and 5 mg and end.
B- 45 mg prednisone / day until there are 3 days of undetected protein in urine and then 30 mg / day for two weeks and to 30,20,10,5 mg until treatment is ended.
C- treatment of twice daily prednisone 30 mg per day until there are 3 days of undetectible protein in urine and then tapering down to 20 ,10 ,5 until treatment is ended.